BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37813065)

  • 1. Chemical exploration of TGR5 functional hot-spots: Synthesis and structure-activity relationships of C7- and C23-Substituted cholic acid derivatives.
    Rosatelli E; Carotti A; Cerra B; De Franco F; Passeri D; Pellicciari R; Gioiello A
    Eur J Med Chem; 2023 Dec; 261():115851. PubMed ID: 37813065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
    Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
    J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5.
    Macchiarulo A; Gioiello A; Thomas C; Massarotti A; Nuti R; Rosatelli E; Sabbatini P; Schoonjans K; Auwerx J; Pellicciari R
    J Chem Inf Model; 2008 Sep; 48(9):1792-801. PubMed ID: 18698841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of 12β-methyl-17-epi-18-nor-bile acids as potent and selective TGR5 agonists.
    Luxenburger A; Harris LD; Ure EM; Jiao W; Woolhouse AD; Cameron SA; Weymouth-Wilson A; Furneaux RH; Pitman JL; Hinkley SFR
    Eur J Med Chem; 2023 Mar; 250():115143. PubMed ID: 36841086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel cholic acid derivatives as highly potent agonists for G protein-coupled bile acid receptor.
    Qian M; Luo Z; Hou W; Sun J; Lu X; Zhang Q; Wu Y; Xue C; Zhao S; Chen X
    Bioorg Chem; 2022 Mar; 120():105588. PubMed ID: 34979448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and biological evaluation of cholic acid derivatives as potent TGR5 positive allosteric modulators.
    Li Y; Sun J; Wang X; Luo Z; Shao X; Li Y; Cao Q; Zhao S; Qian M; Chen X
    Bioorg Med Chem; 2023 Sep; 92():117418. PubMed ID: 37536263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semisynthetic bile acid FXR and TGR5 agonists: physicochemical properties, pharmacokinetics, and metabolism in the rat.
    Roda A; Pellicciari R; Gioiello A; Neri F; Camborata C; Passeri D; De Franco F; Spinozzi S; Colliva C; Adorini L; Montagnani M; Aldini R
    J Pharmacol Exp Ther; 2014 Jul; 350(1):56-68. PubMed ID: 24784847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semisynthetic bile acids: a new therapeutic option for metabolic syndrome.
    Lazarević S; Đanić M; Goločorbin-Kon S; Al-Salami H; Mikov M
    Pharmacol Res; 2019 Aug; 146():104333. PubMed ID: 31254667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.
    Pellicciari R; Sato H; Gioiello A; Costantino G; Macchiarulo A; Sadeghpour BM; Giorgi G; Schoonjans K; Auwerx J
    J Med Chem; 2007 Sep; 50(18):4265-8. PubMed ID: 17685603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational mapping of the transmembrane binding site of the G-protein coupled receptor TGR5 and binding mode prediction of TGR5 agonists.
    Gertzen CG; Spomer L; Smits SH; Häussinger D; Keitel V; Gohlke H
    Eur J Med Chem; 2015 Nov; 104():57-72. PubMed ID: 26435512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
    Tiwari A; Maiti P
    Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
    Watanabe M; Houten SM; Mataki C; Christoffolete MA; Kim BW; Sato H; Messaddeq N; Harney JW; Ezaki O; Kodama T; Schoonjans K; Bianco AC; Auwerx J
    Nature; 2006 Jan; 439(7075):484-9. PubMed ID: 16400329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.
    Li S; Qiu M; Kong Y; Zhao X; Choi HJ; Reich M; Bunkelman BH; Liu Q; Hu S; Han M; Xie H; Rosenberg AZ; Keitel V; Kwon TH; Levi M; Li C; Wang W
    J Am Soc Nephrol; 2018 Nov; 29(11):2658-2670. PubMed ID: 30305310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.
    Rizzo G; Passeri D; De Franco F; Ciaccioli G; Donadio L; Rizzo G; Orlandi S; Sadeghpour B; Wang XX; Jiang T; Levi M; Pruzanski M; Adorini L
    Mol Pharmacol; 2010 Oct; 78(4):617-30. PubMed ID: 20631053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor.
    Abrigo J; Gonzalez F; Aguirre F; Tacchi F; Gonzalez A; Meza MP; Simon F; Cabrera D; Arrese M; Karpen S; Cabello-Verrugio C
    J Cell Physiol; 2021 Jan; 236(1):260-272. PubMed ID: 32506638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
    Donepudi AC; Boehme S; Li F; Chiang JY
    Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of the bile acid receptor TGR5 in metabolism.
    van Nierop FS; Scheltema MJ; Eggink HM; Pols TW; Sonne DP; Knop FK; Soeters MR
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):224-233. PubMed ID: 27639537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Selective TGR5 Ligands Based on the 5,6,7,8-Tetrahydro-5,5,8,8-tetramethylnaphthalene Skeleton.
    Terui R; Yanase Y; Yokoo H; Suhara Y; Makishima M; Demizu Y; Misawa T
    ChemMedChem; 2021 Feb; 16(3):458-462. PubMed ID: 32969181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
    Jadhav K; Xu Y; Xu Y; Li Y; Xu J; Zhu Y; Adorini L; Lee YK; Kasumov T; Yin L; Zhang Y
    Mol Metab; 2018 Mar; 9():131-140. PubMed ID: 29361497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.